Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Kazes

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 2016
Homocitrulline as marker of protein carbamylation in hemodialyzed patientsStéphane Jaisson, Isabelle Kazes, Aurore Desmons, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Clinical Kidney Journal|December 23, 2020
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohortGuillaume Lano, Antoine Braconnier, Stanislas Bataille, et al.
Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 16, 2016
Homocitrulline as marker of protein carbamylation in hemodialyzed patientsStéphane Jaisson, Isabelle Kazes, Aurore Desmons, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Clinical Kidney Journal|December 23, 2020
Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohortGuillaume Lano, Antoine Braconnier, Stanislas Bataille, et al.
Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.
Pageof 2